Table 3.
Patients’ clinical characteristics, according to fulfillment (BGRev+) or nonfulfillment (BGRev-) of at least one criterion of the revised Bethesda guidelines
| Variable | BGRev- (n = 105) | BGRev+ (n = 45) | All patients (n = 150) | P |
|---|---|---|---|---|
|
Women/men |
43/62 |
17/28 |
60/90 |
0.351* |
|
Mean age ± standard deviation (range) |
65.1 ± 10.3 |
51.6 ± 9.9 |
61.08 ± 10.3 |
<0.001† |
|
Localization: |
0.712* |
|||
| rectum |
52 |
23 |
75 |
|
| left colon |
34 |
13 |
47 |
|
| right colon |
19 |
9 |
28 |
|
|
Patients with synchronous or metachronous colorectal cancer |
0 |
5 |
5 |
|
| Union for International Cancer Control disease stage: |
0.572* |
|||
| I |
7 |
6 |
13 |
|
| II |
38 |
14 |
52 |
|
| III |
46 |
19 |
65 |
|
| IV | 14 | 6 | 20 |
*χ2 test.
†t-test.